Pretreatment Systemic Inflammation Response Index in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator

Cancer Management and Research - New Zealand
doi 10.2147/cmar.s235519
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

CD44v9 as a Poor Prognostic Factor of Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy

Breast Cancer
Nuclear MedicineRadiologyPharmacologyOncologyImagingMedicine
2018English

Association of Pretreatment Anemia With Pathological Response and Survival of Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Population-Based Study

PLoS ONE
Multidisciplinary
2015English

Epigenetic Changes Associated With Inflammation in Breast Cancer Patients Treated With Chemotherapy

Brain, Behavior, and Immunity
EndocrineImmunologyBehavioral NeuroscienceAutonomic Systems
2014English

Predictive and Prognostic Role of Metabolic Response in Patients With Stage III NSCLC Treated With Neoadjuvant Chemotherapy

Clinical Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2020English

Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Patients With Cervical Cancer

Scientific Reports
Multidisciplinary
2019English

Evaluation of Prognostic Factors and Validation of Tumor Response Ratios After Neoadjuvant Chemotherapy in Patients With Breast Cancer

Journal of Breast Disease
2016English

Predictors of Recurrence in Breast Cancer Patients With a Pathologic Complete Response After Neoadjuvant Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
2010English

Long-Term Prognostic and Predictive Factors in 107 Stage II/III Breast Cancer Patients Treated With Anthracycline-Based Neoadjuvant Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
1997English

ERCC1 Codon 118 Polymorphism Is a Useful Prognostic Marker in Patients With Pancreatic Cancer Treated With Platinum-Based Chemotherapy

International Journal of Oncology
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy